{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-002154","form_type":"8-K","ticker":"PMHS","cik":"0001265521","company_name":"Polomar Health Services, Inc.","filed_at":"2025-01-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.156506+00:00","generated_at":"2026-05-28T01:44:41.374503+00:00","sec_items":["9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Polomar Health amends license with Pinata; adds pharmacy sub, sets royalties of 10-20%","bullets":["Amended license covers metformin (10% royalty), semaglutide/liraglutide (20%), sumatriptan/sildenafil (15%).","License is worldwide, non-exclusive, perpetual; may be terminated with 180 days notice or for uncured breach.","Polomar Specialty Pharmacy, a wholly-owned Florida subsidiary, added as a licensee.","Pinata is an affiliate of CWR 1 LLC, Polomar's majority shareholder (common ownership)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-002154","json":"https://secwatch.observer/filing/0001493152-25-002154.json","markdown":"https://secwatch.observer/filing/0001493152-25-002154.md","text":"https://secwatch.observer/filing/0001493152-25-002154.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1265521/000149315225002154/0001493152-25-002154-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1265521/000149315225002154/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T01:44:41.374503+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}